Paige, a leader in next-generation AI technology, together with NHS Wales, has announced the launch of a new pilot project at Betsi Cadwaladr University Health Board (BCUHB). The project will evaluate how Paige’s AI-assisted diagnostic application, Paige PanCancer Detect, can streamline pathology workflows and enhance patient care by triaging routine clinical cases.
Health Technology Insights: Advancium Backs SARM1 Inhibitor Research for Rare Eye Disease
“Through this pilot, we aim to establish the real-world utility of AI to prioritize potentially malignant cases and reduce diagnostic delays,”
The pilot will be the first clinical use of Paige PanCancer Detect and involve the prospective assessment of cases across all tissue types consecutively received for routine evaluation. This will determine whether the use of AI can shorten turnaround times for malignant case assessments and facilitate earlier detection of cancer to get the results to patients faster.
“Through this pilot, we aim to establish the real-world utility of AI to prioritize potentially malignant cases and reduce diagnostic delays,” said Dr. Alistair Heath, Histopathologist at BCUHB. “By analyzing the impact on turnaround times and diagnostic accuracy, we can begin to understand how to better support quality improvement, more efficient patient management, and ultimately, faster results for patients.”
Each case will be analyzed using Paige PanCancer Detect, developed using more than three million pathology slides, to predict whether a whole slide image (WSI) is benign or suspicious for cancer. Cases flagged as suspicious will be prioritized for pathologist review, while those marked as benign will follow the standard workflow.
Health Technology Insights: Cigna, Singleton Ink Multi-Year Deal to Expand Radiology in Texas
“We are committed to exploring how innovative technologies can support our pathology services and ultimately benefit patients across North Wales,” said Dr. Muhammad Aslam, Consultant Pathologist and Clinical Director for North Wales Diagnostic and Specialist Clinical Services. “This pilot represents an important step toward that vision, and we are pleased to be working on this initiative.”
“We are thrilled to support this pioneering pilot with NHS Wales,” said Dr. Juan Retamero, Medical Vice President at Paige. “Paige PanCancer Detect was designed to assist pathologists across tissue types, and this project provides a valuable opportunity to see it in action in a clinical setting.”
The pilot builds on the success of Paige being awarded an NHS tender to conduct a larger-scale study and the service improvement project will expand to include additional health boards across Wales.
Health Technology Insights: Free Market Health Acquires Beeline Rx, Enhances with AI Onboarding
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
